Newborns and individuals with Alzheimer's disease have been found to share an unusual biological feature: both show high levels of a well-established Alzheimer's biomarker. What do newborns and ...

A groundbreaking study from the Centre for Addiction and Mental Health (CAMH) in Canada has revealed that an experimental ...

The study, carried out by experts from the University of Nottingham, found that there was nearly a 50% increased risk of ...

When I visited a nursing home for several years, I met two men who were there after suffering major injuries taking care of their wives. One broke a hip, another shattered a knee. Both times, they ...

The new dosing schedule with a more gradual titration significantly lowered incidence of ARIA-E in the TRAILBLAZER-ALZ 6 trial.

Quest will offer the first FDA-approved blood test to help detect Alzheimer’s-related amyloid pathology in patients with ...

Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...

Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...

The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...

A new dosing regimen for Kisunla, to help lower the risk of certain side effects, has been approved by the U.S. Food and Drug ...

A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...